Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PMV Pharmaceuticals, Inc. | 6,204,153 | reported | 29 Sept 2020 | tx 18+12,939,267−12,828,712 |
| NOVACEA INC | 1,983,884 | reported | 21 Sept 2011 | tx 1+217,228 |
| MACROGENICS INC | 1,708,716 | reported | 18 Feb 2014 | tx 12+1,922,565−28,539,874 |
| DYNAVAX TECHNOLOGIES CORP | 25,000 | reported | 28 May 2020 | tx 32+1,984,060−2,574,784 |
| Marketo, Inc. | 15,000 | reported | 28 Feb 2014 | tx 12+123,510−599,420 |
| APPLIED GENETIC TECHNOLOGIES CORP | 11,208 | reported | 24 Apr 2017 | tx 17+1,486,687−35,909,740 |
| METABASIS THERAPEUTICS INC | 10,000 | reported | 23 Jun 2009 | tx 34+4,109,504−2,621,578 |
| CORGENTECH INC | 10,000 | reported | 09 May 2008 | tx 6+2,002,809 |
| KalVista Pharmaceuticals, Inc. | 7,000 | reported | 01 Oct 2020 | tx 6+97,824 |
| CORIXA CORP | 5,000 | reported | 28 May 2004 | tx 2+12,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Oct 2020 | GRANT_AWARD | KalVista Pharmaceuticals, Inc. | 7,000 | 0.00 USD | deriv |
| 29 Sept 2020 | CONVERSION | PMV Pharmaceuticals, Inc. | 3,488,398 | — | |
| 29 Sept 2020 | CONVERSION | PMV Pharmaceuticals, Inc. | 1,040,654 | — | |
| 29 Sept 2020 | CONVERSION | PMV Pharmaceuticals, Inc. | 1,620,101 | — | |
| 25 Sept 2020 | PURCHASE | PMV Pharmaceuticals, Inc. | 55,000 | 18.00 USD | |
| 29 Sept 2020 | CONVERSION | PMV Pharmaceuticals, Inc. | 265,203 | — | |
| 29 Sept 2020 | CONVERSION | PMV Pharmaceuticals, Inc. | 3,488,398 | 0.00 USD | deriv |
| 29 Sept 2020 | CONVERSION | PMV Pharmaceuticals, Inc. | 1,040,654 | 0.00 USD | deriv |
| 29 Sept 2020 | CONVERSION | PMV Pharmaceuticals, Inc. | 265,203 | 0.00 USD | deriv |
| 29 Sept 2020 | CONVERSION | PMV Pharmaceuticals, Inc. | 1,620,101 | 0.00 USD | deriv |
| 28 May 2020 | GRANT_AWARD | DYNAVAX TECHNOLOGIES CORP | 25,000 | — | deriv |
| 02 Oct 2019 | GRANT_AWARD | KalVista Pharmaceuticals, Inc. | 7,000 | 0.00 USD | deriv |
| 20 Aug 2019 | PURCHASE | Venus Concept Inc. | — | 2000000.00 USD | deriv |
| 30 May 2019 | GRANT_AWARD | DYNAVAX TECHNOLOGIES CORP | 15,000 | — | deriv |
| 03 Oct 2018 | GRANT_AWARD | KalVista Pharmaceuticals, Inc. | 7,000 | 0.00 USD | deriv |
| 10 Sept 2018 | PURCHASE | KalVista Pharmaceuticals, Inc. | 58,824 | 17.00 USD | first after silence |
| 07 Aug 2018 | EXERCISE | TESARO, Inc. | 10,000 | 0.00 USD | |
| 07 Aug 2018 | SALE | TESARO, Inc. | 10,000 | 26.77 USD | |
| 07 Aug 2018 | EXERCISE | TESARO, Inc. | 10,000 | 0.00 USD | deriv |
| 31 May 2018 | GRANT_AWARD | DYNAVAX TECHNOLOGIES CORP | 15,000 | — | deriv |
| 27 Sept 2017 | GRANT_AWARD | KalVista Pharmaceuticals, Inc. | 6,000 | 0.00 USD | deriv |
| 01 Jun 2017 | GRANT_AWARD | TESARO, Inc. | 335 | 0.00 USD | |
| 01 Jun 2017 | GRANT_AWARD | TESARO, Inc. | 12,000 | 0.00 USD | deriv |
| 02 Jun 2017 | GRANT_AWARD | DYNAVAX TECHNOLOGIES CORP | 7,500 | — | deriv |
| 24 Apr 2017 | EXERCISE | APPLIED GENETIC TECHNOLOGIES CORP | 28 | — |
6 purchases reported after at least 12 months of silence — most recent on 10 Sept 2018.